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ABSTRACT  
  
  
  
Jaggers, Robert Maxwell.  M.S. Department of Neuroscience, Cell Biology and 
Physiology, Wright State University, 2015.  Is Polyvinylidene diflouride (PVDF) film 
biocompatible in the Murine Cochlea?  
  
  
Polyvinylidene fluoride (PVDF) film, a biomaterial that is an integral part of a 
Totally Implantable Sustainable Hearing Aide (TISHA) device, was examined to 
determine its biocompatibility within the murine cochlea.  The biofilm was implanted 
in the ear using a round window cochleostomy in 7-9 week old male C57BL/6 mice.  
Three test groups containing seven mice each were implanted with PVDF film.  Each 
mouse received a sham surgery on the non-implanted cochlea.  Three test groups 
were examined at 48 hours, 3 weeks, and 3 months.  At the end of this time the mouse 
was euthanized, the tissue containing the cochlea was extracted, decalcified in cal-rite 
solution, processed through a gradient of alcohols and xylene and embedded in 
paraffin.  Slides were made and stained with Hemotoxylin and Eosin.  The degree of 
the Foreign Body Reaction (FBR) in the cochlea with the implanted biofilm was 
determined quantitatively and qualitatively using nonparametric and parametric 
tests.   
We found that quantitatively the amount of erythrocytes significantly 
decreased between the 48 hour and 3 week survival length groups (1-way ANOVA, P-
value=.020). The amount of neutrophils significantly decreased between the 48 hour 
and 3 week (1-way ANOVA, P-value=0.22) and 48 hour and 3 month survival length 
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groups (1-way ANOVA, P-value=0.28). Membrane formation around the implant and 
presence of foreign body giant cells (FGBCs) and fibrocytes were evident in the 
chronically implanted animals (≥ 3 weeks).  Damage to inner and outer hair cells of 
the Organ of Corti was observed in both implanted and control cochlea.  Angiogenesis, 
a normal phase of the healing process, was significant only in the 3 week survival 
group (Fisher’s exact test, P-value=.0002).    
Animals were assigned individual scores that were related to a certain 
intensity level of the FBR. There was a significant increase in the average score of the 
FBR between the 48 hour and 3 week survival length group (Kruskal-Wallis test, P-
value=.030).  The majority of animals were assigned the lowest intensity level, very 
mild, while 3 animals received a mild intensity rating. 
We determined that PVDF film was biocompatible based on the observation 
that acute responses of the FBR decreased after the initial time of implantation, 
chronic response of the FBR did not progress in intensity after the 3 week time point, 
the average rank of the FBR was the lowest score on our intensity scale, and the 
components of the FBR did not spread from the site of implantation into surrounding 
areas of the cochlea. PVDF film did not interrupt the healing process of the host such 
as the clotting mechanism or become extruded from the cochlea. 
This work appeared in abstract form at  the Celebration of Research, Scholarship, and 
Creative Activities 2015 and Ohio Miami Valley Chapter of the Society for Neuroscience, 
Neuroscience day 2015. 
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 I.  INTRODUCTION   
 
 A medical material, prosthesis, or device is defined as biocompatible if it 
resides in an organism with the absence of prolonged damage to host tissue or 
interruption of normal physiological mechanisms.  Biocompatible materials and 
devices are used extensively in several disciplines; electrode arrays designed to 
record neural signals from the brain in neuroscience, polymer capsules that deliver a 
drug to a specific area of the body in medicine, or even gold alloys and porcelain 
polymers used for dental reconstruction (Davis, 2003).  Cell lineages have also been 
combined with collagen to be used as grafts for integument and bone repair or 
replacement (Hollinger, 2012). Dermagraft (Organogensis, MA), a mesh-like material 
that mimics the extracellular matrix of the cellular ultrastructure, was designed to 
assist the body during skin regeneration after injury (Hollinger, 2012).  In addition to 
the aforementioned definition, a biomaterials main functional role is to replace, 
monitor, enhance, or diminish a certain tissue, organ or physiological mechanism 
(Black, 1999).    
One area of biomedical research has focused on constructing devices designed 
to ameliorate deficits in the auditory system. These biomaterials are used as 
replacements for anatomical structures of the ear, initiators of drug delivery systems 
used to treat hearing loss, and implanted devices that replicate the physiological 
mechanism of the auditory pathway.  
 Damage to the auditory ossicles of the middle ear following chronic disease 
states can impair or negate vital steps in the auditory pathway. Chronic suppurative 
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otitis media (CSOM), a chronic infectious disease that is a cause of hearing 
impairment, can be corrected by auditory ossicle replacement.  The Goldenberg 
hydroxyapatite implant system can be used as a total or partial ossicular bone 
prosthesis. (Goldenberg and Driver, 2000).  Hydroxyapatite, an established 
biomaterial, is a porous, ceramic compound that resembles human bone (Goldenberg 
and Driver, 2000).  In recent years, cortical bone has also been shown to be a possible 
biomaterial that can be used for auditory ossicle replacement (Malhotra et al., 2014).  
Platinum, a known biomaterial that has been incorporated into several prosthesis 
designs, is also a common material used to replace auditory ossicles (Shah et al., 
2013).  These approaches are designed to treat deficits attributed to conductive 
hearing loss.   
 A relatively new approach at treating sensorineural hearing loss is through 
the use of a drug delivery system that targets the source of the malady in the cochlea 
(Nakagawa, 2007). Sensorineural hearing loss can arise from damage to the Organ of 
Corti, the area of the cochlea that contains the main cellular receptors for hearing, or 
the neuronal connections between the cochlea and the auditory cortex located in the 
cerebrum (Inaoka et al., 2011) (Isaacson et al.,2003).  Micro-implants made of silicone 
have been shown to deliver steroids, such as beclamethasone, to cochlear fluids 
without causing damage to histological or functional aspects of the cochlea 
(Nakagawa, 2007). The intended result of steroid therapy in the cochlea is to decrease 
inflammation that is a result of damage to cochlear structures.  
Another current method for treating severe to profound hearing loss arising 
from nerve deafness is through cochlear implant devices. These devices replace a 
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specific step in the auditory pathway by converting   auditory stimuli into electrical 
impulses. The electrical impulse transfers sensory information to the 
vestibulocochlear nerve, cranial nerve VIII (Wilson and Dorman, 2008). Damage can 
arise from many different sources including bacterial infections, pharmaceutical 
agents, geriatric deficiencies, and exposure to loud noises (Wilson and Dorman, 
2008). The cochlear implant (CI) is an example of a current implantable device used 
to treat auditory deficiencies. CIs replace the function of the sensory epithelium, 
known as hair cells, located in the cochlea (Wilson and Dorman, 2008). A CI has both 
external and internal components; a power source, microphone, and speech 
processor are located externally and involved in the conversion of sound waves into 
electrical energy that is then transferred to an electrical array located internally 
within the cochlea (Wilson and Dorman, 2008).  The electrode array circumvents the 
damaged sensory hair cells of the cochlea and stimulates the auditory nerve.  The 
study discussed in this paper examines a material that performs this function and is 
an integral part of a newly designed cochlear implant device.   
Our study analyzed the biocompatibility of polyvinylidene difluoride (PVDF) 
film when implanted in the mouse cochlea.  PVDF film is an integral part of a Totally 
Implantable and Sustainable Hearing Aid (TISHA) device. The foundation of the 
TISHA device is built upon principles used in the CI.  The device, currently in the 
experimental stage, is composed of a completely internal structure that is implanted 
in the cochlea. Biocompatibility will be assessed through the analysis of cochlear 
histological reactions to the implanted film which will determine the intensity level 
of the Foreign Body Reaction (FBR).  
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Biocompatibility Testing 
Before a device can be deemed suitable for human use, the reaction of viable 
tissue to the materials that are used in the device must be established using 
biocompatibility studies. Biocompatibility testing incorporates in vitro and in vivo 
examinations to determine the degree of cytotoxicity, infection, immunogenicity, 
hemocompatibility, and inflammation to verify one basic principle of the test 
material:  Is the material compatible with different cell lineages and tissues.   
One of the initial objectives of material biocompatibility examinations involves 
in vitro cellular trials to evaluate the degree of cytotoxicity. Cytotoxicity evaluation is 
performed to establish if leachable particulates that accumulate over the life span of 
the implant are harmful to viable tissue (Silver and Doilon, 1989). Time constrained 
assays combine a biomaterial with different cell lineages to analyze levels of necrosis 
and overall viability of the cells with the use of vital stains (Silver and Doilon, 1989).  
A 2010 study conducted by Shintaku and colleagues examined the in vitro 
compatibility of the components of an implantable artificial cochlea. The implantable 
artificial cochlea is chiefly composed of PVDF, trifloroethylene (TrFe), silicon, and 
platinum (Shintaku et al., 2010). Cell cultures combining Rattus rattus cerebral cortex 
neurons with the artificial cochlea materials were created with cell adhesion factors 
made from human fibronectin. Bovine collagen was used to adhere the neurons to the 
implant surface (Shintaku et al., 2010). After applying fluorescent Nissl stains to 
neuronal sections, fluorescent microscopy confirmed that the cultured neurons were 
viable and showed axonal and dendritic outgrowths. This led them to conclude that 
PVDF film combined with the three artificial cochlea materials, were non-cytotoxic 
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(Shintaku et al., 2010). A previous study analyzed the cytotoxicity and 
hemocompatibility in vitro of polyethylene terephthalate (PET) fabric coated in PVDF 
(Joseph et al., 2008). Sections of PET coated in PVDF were placed in direct contact 
with L-929 fibroblast cells, whole blood mounts, and human endothelial cells.  
Observations showed that the PVDF material did not adversely affect viability of the 
cell linages. 
 Once a material has been shown to be non-cytotoxic it is incorporated into in 
vivo studies. In vivo animal studies can measure the compatibility of a material to 
different tissue types, such as blood or bone, in a viable organism. Acute and chronic 
treatments are utilized to measure the amount of irritation, inflammation, and if 
infectious agents are present.  Unresolved chronic inflammation can not only be 
detrimental to the host, but also compromise the function of the biomaterial (Silver 
and Doilon, 1989). Histological analysis utilizing light or electron microscopy is an 
effective technique to quantify the degree of inflammation, both acutely and 
chronically, along with fibrotic capsule formation in harvested tissue containing the 
implanted material (Anderson, 2001). A previous study conducted by Gerullis and 
colleagues compared the in vivo host reaction to PVDF film mesh and two other 
polymer meshes. When harvested at different time points, the short term implanted 
PVDF film showed signs of macrophage infiltration and exudate associated with the 
acute inflammatory response (Gerullis et al., 2014). When compared to the two 
remaining polymer meshes, PVDF film had the lowest long term levels of measured 
components of chronic inflammation such as connective tissue and angiogenesis 
formation at the site of implantation (Gerullis et al., 2014). The study noted that even 
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though PVDF mesh showed the lowest levels of inflammation in the chronic implant 
group, PVDF film had the highest level of macrophage infiltration acutely among the 
three mesh implants.  
After the biocompatibility of a material has been established in the presence 
of different cell lineages and within an animal model the next step is clinical trials 
involving human participants.  Clinical trials incorporate several steps known as 
phases and involve a completely designed material or device that is implanted in a 
human participant under tightly controlled conditions and strict observation.  In the 
case of PVDF film, the clinical trial would be concerned with the performance of the 
film as a component within the TISHA device.  Clinical trials are the final examinations 
that biomaterials must undergo in order to establish that they can be implanted 
within the human body (Black, 1999). 
Building off past in vitro and in vivo test results, this study examined the in vivo, 
nonfunctional biocompatibility of PVDF film in the mouse cochlea. Harvested tissue 
containing the implant material was stained with Hemotoxylin and Eosin and both 
quantitatively and qualitatively analyzed to measure select parameters of 
inflammation, such as the amount of inflammatory cells, areas of necrotic tissue, and 
amount of capsular formation on the surface of the implant (Silver and Doilon, 1989). 
  
Foreign Body Reaction to an Implanted Material  
 
When an external barrier of the body, such as integument or a mucous 
membrane is subjected to a traumatic event or breached by a foreign object a specific 
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defense mechanism is elicited by the host.  This response to injury, and the overall 
mechanism of the healing process, is set in motion by an inflammatory response. The 
inflammatory response is a nonspecific stereotyped reaction by the host to a stimulus 
that can vary greatly in intensity (Slauson and Cooper, 1982).  The inflammatory 
response can be characterized by four “cardinal signs,” calor (heat), rubor (redness), 
tumor (swelling), and dolor (pain) (Slauson and Cooper, 1982).    The mediators of 
the inflammatory response are blood derived that use vasculature as a conduit to 
reach the site of injury (Slauson and Cooper, 1982).  There are derivations to the 
inflammatory response that depend on the type and duration of the stimulus.  This 
research is concerned with the type of inflammation that encounters a foreign object 
implanted in the host. 
Infection at the site of implantation can have detrimental effects to the 
surrounding tissue. Infection can lead to tissue inflammation and changes in cellular 
structure, most notably hypertrophy and hyperplasia (Silver and Doilon, 1989).  
Infection can arise from improper sterilization techniques and compounds composed 
of biomaterials that interrupt the ability of leukocytes to properly function during the 
inflammatory response (Silver and Doilon, 1989).  Infection is the colonization and 
growth of microorganisms such as bacteria that can be the result of a surgical 
procedure to implant a biomaterial (Black, 1999).  Infection can cause considerable 
damage to the host and in extreme cases can increase the rate of necrosis, the death 
of living tissue.  Necrotic tissue can be observed in many different states and can 
result from toxins produced by fungi and bacteria (Cheville, 1988).  Peptide 
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components can be released from necrotic tissue which can instigate inflammation 
(Cheville, 1988). 
 The term for the collective processes that are initiated during the 
implantation of a foreign material in the body is known as the Foreign Body Reaction 
(FBR).    This initial phases of the FBR are set into motion when a foreign material is 
implanted and establishes an interface with tissue.  This is the case even for 
biocompatible materials that are deemed non-toxic, non-immunogenic, and stable 
compounds. (Hu et al., 2001) The extent and magnitude of the FBR varies depending 
on the physical and chemical properties of the material and the overall health, species, 
and age of the host (Anderson, 2001).  These parameters determine the degree of the 
FBR which can serve as one method to measure the biocompatibility of a material. 
The FBR is used to repair and remodel damaged tissue and degenerated cells, 
recruit specific immune cells to the site of implantation, and seal off and if possible 
degrade the material that composes the foreign object. The key events of the FBR are 
illustrated in Figure 1. Fibrotic encapsulation resulting from fibrous tissue 
production will inevitably accompany any foreign object implanted in vascular tissue 
(Anderson, 2001).  Within the first minutes of implantation serum plasma proteins 
leave the vasculature and are attached and absorbed to the foreign object’s surface.  
The marked increase in permeability in capillary endothelial cells and dilation of 
capillaries around the site of injury caused by the foreign body can be implemented 
by vasoactive amines such as histamine and serotonin.  Mast cells residing in the 
tissue are one source of released histamine (Slauson and Cooper, 1982).  Erythrocyte 
accumulation causes edema formation at the site of implantation. Vasodilation and 
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increased permeability in microvessels provides avenues for the passage of both 
plasma proteins and circulating leukocytes out of systemic circulation (Slauson and 
Cooper, 1982). Trauma to vasculature that leads to hemorrhage can also serve as a 
route for plasma proteins to be exposed to the implant.  These plasma proteins create 
a thin layer around the material. The matrix formed as a result of protein absorption 
to the material’s surface is related to thrombus formation at the site of implantation 
and is mainly composed of fibrin, endothelial cells, platelets, and inflammatory cells 
(Anderson, 2001). Fibrinogen is the main plasma protein that contributes to the 
encapsulation of the foreign object, along with serum albumin and immunoglobins 
(Hollinger, 2012).  The layer created on the material’s surface serves as an interface 
between the object and the body; signaling molecules released from the protein layer 
recruit inflammatory cells to the site of the foreign object which initiate the preceding 
steps in the FBR. A previous study has shown that the absorption of the plasma 
protein fibrinogen to an implant’s surface exposes specific protein epitopes that are 
essential for recruitment of macrophages to the site of implantation (Hu et al., 2001). 
 Among the attracted inflammatory cells, the two most abundant phagocytic 
leukocytes are neutrophils and monocytes, the latter giving rise to macrophages.  Two 
main roles of these immune cells are to degrade the foreign material through the 
production and excretion of enzymes housed in lysosomes and ultimately 
phagocytize particulates of the degraded foreign body.   Enzymes are tailored to 
specifically degrade certain macromolecules; Cathepsins specifically degrade 
proteins, Acid Ribonuclease degrades the nucleic acid RNA, Acid Lipase degrades 
lipids, and Lysozyme degrades carbohydrates (Slauson and Cooper, 1982).  The first 
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inflammatory cells to arrive and degenerate in the shortest amount of time are 
neutrophils.  Neutrophils, along with basophils and eosinophils are classified as a type 
of leukocyte known as granulocytes. Granulocytes are a distinct class of leukocytes 
because they contain specific granules. Agranulocytes are the other class of 
leukocytes that do not contain specific granules. Lymphocytes and monocytes are 
classified as agranulocytes (Gartner and Hiatt, 2007). Neutrophils are the majority of 
circulating granulocytes in the blood and during acute inflammation.  Neutrophilic 
enzymes are housed in both specific, azurophilic, and tertiary granules (Gartner and 
Hiatt, 2007). Within the first few hours of implantation, circulating neutrophils in the 
blood begin to adhere to luminal side of endothelial cells of vasculature located near 
the implant.  Through a process known as diapedesis, circulating leukocytes exit the 
blood vessels and pass through gaps created between endothelial cells.  Along with 
signaling factors, changes in the local pH and chemical configuration can 
chemotactically recruit additional neutrophils to the site of implantation (Black, 
1999). Additionally, opsonins, which include antibodies, complement factors, and 
lysozyme, mark foreign objects and make them more attractive to immune cells 
through a process known as opsonization (Slauson and Cooper, 1982).  
Two mononuclear phagocytes that are recruited to sites of injury are 
monocytes and macrophages. After exiting the vasculature both cell types migrate to 
the site of inflammation. Macrophages are attracted to the site of injury by several 
types of cytokines including macrophage colony stimulating factor (M-CSF) and 
interferon λ (Black, 1999).  Macrophages, found in circulation and also residing in 
tissue, are the major cell type of chronic inflammation, releasing signaling factors that 
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dictate many aspects of the healing process such as angiogenesis and recruitment of 
fibroblasts and additional inflammatory cells to the site of injury (Anderson, 2001).   
Fibroblasts, the mitotically active counterpart of fibrocytes, are normally 
found in wounds and assist in the process of sealing off and separating the foreign 
material from the rest of the body. Fibroblasts are attracted to the site of implantation 
through several pathways: platelet-derived growth factor (PDGF) and transforming 
growth factor β (TGF-β), which are released by platelets, monocytes, and 
lymphocytes (Anderson, 2001).  Matrices of collagen and proteoglycans are formed 
by fibroblasts around the foreign object (Hollinger, 2012). This avascular tissue, 
known as granulation tissue, is composed of fibroblasts encased in the secreted 
extracellular matrix (Silver and Doilon, 1989). The collagen matrix is mainly 
composed of Type III collagen with Type I being the main component of the matrix as 
the healing process progresses (Silver and Doilon, 1989).  This matrix can also contain 
vascular growths that give evidence to angiogenesis at the site of implantation 
(Cheville, 1988).  Capillaries are formed as a response to hypoxic conditions, signaling 
factors from neutrophils, and heparin released from mast cells (Cheville, 1988).  
One final cell lineage observed during a FBR is formed from the fusion of 
monocytes and macrophages.  Foreign Body Giant cells (FBGCs) are formed when an 
encountered foreign object is too large or simply unable to be degraded by a 
macrophage.  One common class of giant cells are Osteoclasts which are found in bone 
and function in bone resorption (Anderson, 2001).  FBGCs are observed in the latter 
stages of inflammation and are normally found within close proximity to the foreign 
object. Interleukin 4 (IL-4) is one known activator of FBGs formation released from 
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macrophages (Anderson, 2001). They have a dual function as immune cells which is 
to release proteolytic enzymes to degrade the material and signaling factors to recruit 
inflammatory cells to the site of injury (Hollinger, 2012).  Known to be present at the 
implant surface decades after the initial implantation, FBGCs configuration is dictated 
by the physical properties of the foreign object.  Rough surfaced implants such as 
Teflon grafts found in vasculature have a greater amount of FBGCs adhering to their 
surface compared to flat, smooth implants that are normally subjected to only a few 
layers of FBGCs and accompanying macrophages (Anderson, 2001). 
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Figure 1. 
Illustration of events that comprise the Foreign Body Reaction of the 
host to an implanted material over time (Grainger 2013).  
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Figure 1. 
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PVDF film as a component of the TISHA Device 
Polyvinylidene difluoride, PVDF, is a translucent, plastic fluoropolymer that 
has applications across several fields (Piezotech, 2015). PVDF is used in acoustical 
devices including microphones and sonar equipment.  Pertaining to the medical field, 
PVDF has been used in blood pressure monitors and pressure sensors in artificial skin 
(Piezotech, 2015). PVDF material is manufactured in a film form because of the 
materials ability to exist in a solid crystalline phase. One unique property of the PVDF 
biofilm is its capability to elicit the piezoelectric effect. When combined with a metal 
polymer, polarized PVDF film will produce an electric charge when subjected to 
mechanical stress. The addition of a metal polymer allows the static charge produced 
on the films surface to propagate into an electrical impulse. The piezoelectric effect 
allows PVDF film to replicate physiological mechanisms that convert mechanical 
energy into electrical impulses.   
The PVDF film is an integral part of a newly designed hearing aid known as the 
Totally Implantable and Sustainable Hearing Aid (TISHA) device. The concept for the 
TISHA device came to fruition through a collaboration of researchers from Wright 
State University (Dayton, OH) and Advratech, LLC (Dayton, OH).  The main advantages 
the TISHA device has over current market hearing aids is its completely internal 
design with the absence of any external apparatuses (antenna or battery) and the 
procedure to implant the device into the inner ear will be minimally invasive. Figure 
2 illustrates the structural differences between the cochlear implant and TISHA 
device. The device will be used to treat hearing loss caused by nerve deafness.  The 
functionality of the device relies on piezoelectric property of the PVDF film. This 
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characteristic of the film allows the device to replicate the function of the cellular 
hearing receptors located within the cochlea.  A study performed by Inaoka and 
colleagues concluded that PVDF film is capable of replicating the hearing receptors 
located specifically in the Organ of Corti of the cochlea in guinea pigs that were 
subjected to drug-induced deafness.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17  
  
Figure 2. 
Comparison of the physical design and differences of the current CI and 
TISHA device. Note the absence of external and implanted devices in the 
TISHA device when compared to the CI (Goldenberg and Zhuang, 2015). 
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Figure 2. 
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Basic Anatomy and Physiology of the Murine Cochlea 
  Sections of PVDF film were implanted in the mouse cochlea. The cochlea was 
chosen as the site of implantation because the ultimate use of the biofilm will be as a 
part of a cochlear implant device.  Our animal model was the C57Bl/6 strain of Mus 
musculus.   Historically, cat (Felis catus) and guinea pig (Cavia porcellus) have been the 
animal model for surgeries involving the auditory system due to the ease of accessing 
the cochlea surgically (Soken et al., 2013).  M. musculus has been incorporated into 
cochlear studies in part due to the accurate modeling of age-related hearing loss as 
observed in the human population (Soken et al., 2013).  
The ear is divided into three regions, the outer, middle, and inner ear.  The 
outer ear is composed of a cartilaginous structure known as the pinna that surrounds 
the external auditory meatus (Scudamore, 2014). Sebaceous and ceruminous glands 
are found on both the outer and inner portions of keratinized squamous epithelium of 
the external auditory meatus (Scudamore, 2014).  The external auditory meatus ends 
at the tympanic membrane, a thin collagenous structure lined with keratinized 
squamous epithelium located externally and respiratory epithelium internally 
(Scudamore, 2014).  
The middle ear is an air-filled chamber lined with simple squamous epithelium 
that is located in the petrous portion of the temporal bone (Gartner and Hiatt, 2001). 
The middle ear houses the three auditory ossicles, the malleus, incus, and stapes. The 
middle ear is connected to the nasopharynx through the pharyngotympanic tube and 
the inner ear through the round and oval windows. The footplate of the stapes bone, 
forms a direct connection with the oval window.  The oval window of the cochlea 
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functions as a conduit for the vibrations produced from sound waves that are 
transferred from the outer ear to the tympanic membrane and then  to the chain of 
auditory ossicles. The vibrations are transferred from the footplate of the stapes to the 
oval window of the cochlea which sets in motion the fluid located in the cochlea 
(Gartner and Hiatt, 2001).   
The comparative anatomical features and physiological mechanisms of the 
cochlea are equivalent among all mammals, including the rodent and human (Forge 
and Wright, 2002). The internal cochlear structures are illustrated in Figure 3. The 
inner ear can be divided into two labyrinths: a membranous labyrinth that contains a 
fluid-filled canal that is connected through a series of membranes and an encasing 
fluid-filled bony labyrinth (Forge and Wright, 2002). The scala media, also known as 
the cochlear duct is found in the membranous labyrinth and contains an extracellular 
fluid known as endolymph that is high in potassium ions (K+) and low in sodium ion 
(Na+). The high positive electrical potential of endolymph (+80 mv) is known as the 
endocochlear potential (EP) (Forge and Wright, 2002).  The EP is essential to the 
transduction of electrical impulses from the Organ of Corti hair cells.   The bony 
labyrinth houses the scala tympani and scala vestibule which both contain perilymph, 
a fluid that has low K+ and high Na+ ionic concentrations that are similar to 
cerebrospinal fluid (CSF) and extracellular fluid found elsewhere in the body.  The 
difference in ionic composition of the endolymph and perilymph fluids is a critical 
aspect of physiological mechanism of hearing. The scala tympani and vestibule are 
joined together at a region near the apex of the cochlea known as the helicotrema 
(Gartner and Hiatt, 2001). Separating the scala media and scala vestibule is a thin layer 
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of epithelium known as Reissner’s membrane. This membrane functions as a barrier to 
separate the two distinct ionic concentrations of the fluids in the scala media and scala 
vestibule. The basilar membrane separates the scala media from the scala tympani 
(Nolte and Sundsten, 2009). The round and oval windows of the cochlea are separated 
by the cochlear promontory. The scala tympani ends at the opening of the round 
window, whereas the scala vestibule ends at the opening of the oval window 
(Scudamore, 2014).   
The scala media houses the Organ of Corti, the area of specialized sensory 
epithelium in the cochlea. Two groups of cells, known as inner and outer hair cells, are 
the main receptors for hearing. Spanning the length of the cochlea, the hair cells are 
organized in rows in the scala media with outer hair cells grouped into 3 rows and 
inner hair cells grouped into one row (Nolte and Sundsten, 2009). Each type of hair cell 
has apical membrane projections identified as microvilli, but commonly referred to as 
stereocilia (Nolte and Sundsten, 2009). The stereocilia are grouped on the apical 
membrane of the hair cells, arranged in order of increasing height and are connected 
to each other through intercellular connections at their apexes known as tip links 
(Nolte and Sundsten, 2009) The outer hair cell stereocilia are embedded in the tectorial 
membrane located in the scala media while the inner hair cell stereocilia are freely 
floating in the scala media (Nolte and Sundsten, 2009). Both sets of stereocilia are 
bathed in the endolymph of the scala media and embedded in the basilar membrane 
(Forge and Wright, 2002). The rigidity and stiffness of the basilar membrane differ 
throughout the cochlea. Near the oval widow, at the base of the cochlea, the basilar 
membrane is less flexible and more rigid compared to the basilar membrane at the 
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apex of the cochlea, near the helicotrema (Guyton and Hall, 2006). This difference in 
membrane stiffness accounts for the observation that different portions of the basilar 
membrane resonate at different sound frequencies (Guyton and Hall, 2006).  
The physiological mechanism of hearing is ultimately dependent on the Organ 
of Corti, specifically inner and outer hair cells, producing an electrical impulse in 
response to interaction with traveling fluid waves in the cochlea (Forge and Wright, 
2002). Once the basilar membrane is set in motion by a traveling wave, the stereocilia, 
which are coupled to the basilar membrane, change their orientation in the scala 
media; deflection toward the tallest stereocilia will depolarize the hair cell, while 
deflection away from the tallest stereocilia will hyperpolarizes the hair cell (Guyton 
and Hall, 2006).  The process of depolarization is initiated by the opening of cationic 
channels in the stereocilia that allow K+ ions from the endolymph to enter the hair cell. 
This sets in motion the process of electrical impulse production which is propagated 
from the hair cells to cochlear nerves fibers (Forge and Wright, 2002). When the hair 
cell depolarizes, voltage-gated Ca2+ channels open causing an influx of Ca2+ into the hair 
cell and allowing the release of neurotransmitter onto nerve fibers (Forge and Wright, 
2002).  The neurotransmitter found in vesicles located in the pre-synaptic area of the 
hair cells has been shown to be glutamate (Nolte and Sundsten, 2009). Outwardly 
rectifying K+ channel are found in the hair cell membrane to facilitate the removal of K+ 
ions after depolarization.  Located alongside the hair cells in the Organ of Corti are 
several classes of supporting cells, such as Dieter’s and Hensen’s cells, that provide 
mechanical support to the hair cells and are also thought to remove excess K+ ions 
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found in the intercellular spaces of the sensory epithelium through gap junctions 
(Forge and Wright, 2002).    
An electrical impulse generated by hair cells travels though nerve endings to 
the cochlear portion of the vestibulocochlear nerve (CN VIII). The spiral ganglion 
located in the modiolus houses the cell bodies of the cochlear nerve. The spiral ganglion 
axons travel to two distinct regions found in the medulla, the dorsal and ventral 
cochlear nuclei (Guyton and Hall, 2006) From the medulla neurons travel 
contralaterally to synapse on the superior olivary nucleus located in the brainstem 
(Guyton and Hall, 2006). From the brainstem auditory neurons travel superiorly to the 
lateral lemniscus of the pons then synapse with the inferior colliculus located in the 
midbrain until finally terminating in the auditory cortex located in the superior gyrus 
of the temporal lobe (Guyton and Hall, 2006). 
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Figure 3. 
Cross-sectional view of a 20x objective control animal image. Shown are the 3 fluid 
filled chambers of the cochlea, scala tympani, scala vestibule, and scala media. 
Reissner’s membrane (RM), the basilar membrane (BM), and tectorial membrane 
(TB) are identified. Note the position of the stria vascularis (SV) and Organ of Corti 
(blue box) in in the scala media. 
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Figure 3. 
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 II.  MATERIALS AND METHODS  
 
All animal experimental and surgical procedures were conducted in the 
Laboratory Animal Resource (LAR) facility with approval of the Wright State 
University Laboratory Animal Care and Use Committee.    
Animal Model and Study Design 
 Adult male C57Bl/6 strains of M.  musculus (Harlan Laboratories, Indianapolis, 
IN) ranging between 20-25 grams in weight and 7-9 weeks of age were subjected to 
a surgical procedure to implant a section of sterile PVDF film within the cochlea. 
Biocompatibility testing that involves implanted devices implements the use of study 
groups that differ in the length of contact with viable tissue (Anderson, 2001). There 
were three groups containing seven mice, all receiving a similar implant and being 
harvested at either an acute (48 hours), moderate  (21 days), or chronic (90 days) 
time point.  The survival length periods were chosen based on Food and Drug 
Administration (FDA) regulations outlined in the Use of International Standard ISO-
10993 for evaluation tests examining the biological effect of implanted devices 
(www.fda.gov/MedicalDevices).  The PVDF film was cut into individual sections 
under a light microscope using a scalpel blade to the approximate dimensions of 1-2 
mm in length and 0.25-0.5 mm in width. Film implants were sterilized pre-operatively 
in an autoclave.    A sham surgery was performed on the contralateral cochlea. Both 
before and following surgery, animals were housed in individuals cages located in 
LAR. 
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 Surgical Procedure Overview 
The procedure used in the study was adapted from a surgery first performed 
by Soken et al. (2013).  The surgery, known as a round window cochleostomy, 
accesses the cochlea through one of its two openings, the round window.  This 
innovative procedure accesses the cochlea from a dorsal approach while reducing 
trauma by sparing surrounding vasculature structures and reducing incision size. A 
similar surgery uses a larger incision site in the ventral area and cauterizes an artery 
(stapedial artery) within close proximity of the cochlea.   
  Each surgery was performed using sterile technique, and instrumentation 
along with implanted materials which were sterilized in an autoclave before surgery.  
Prior to surgery, the animal was anesthetized with a Ketamine (100 mg/kg) and 
Xylazine (10 mg/kg) solution (.1 ml/20 g dosage, intraperitoneal).  Artificial tears 
were applied to both eyes, and the site of incision, caudal to the auricle, was shaved.  
Three applications of alternating Povidone Iodine scrub and 70% Ethyl Alcohol swabs 
followed by a single application of Betadine solution were used to aseptically prepare 
the site of incision.  The animal was placed in the prone position in the horizontal 
plane.  A heating pad was used to counteract the excessive decrease in body 
temperature during the surgery.  A surgical microscope (Zeiss, Germany) was used 
through the extent of the procedure. Anesthesia during the surgery was administered 
through a nose-cone that delivered a gaseous mixture of isoflurane and oxygen to the 
animal.   With the animal placed in the prone position, a post auricular incision, 1.5-2 
cm in length, was made extending through the angle of the mandible (Soken et al. 
2013).  A retractor was placed in the incision following blunt dissection of the 
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subcutaneous tissue.   The great auricular nerve was located crossing over the surface 
of the sternocleidomastoid muscle (SCM) and cut. The SCM was cut at its proximal 
attachment and reflected revealing the tympanic bulla (TB) of the temporal bone with 
the posterior belly of the digastric muscle (PBD) covering its rostral surface.  The TB 
encloses the bony features of the external acoustic meatus, middle ear, and inner ear 
(Hajbi-Yonissi et al., 2007). The components of the inner ear enclosed within the 
rostro-medial portion of the TB are the cochlea, labyrinth and vestibule (Hajbi-
Yonissi et al., 2007).   The rostral portion of the trapezius muscle was excised to reveal 
the facial nerve exiting the cranium through the stylomastoid foramen (SF).  The 
superior portion of the PBD covering the TB, located distally to the facial nerve, was 
removed with a cauterizer (Argent Fine Tip Cautery).  Exposure of the RW of the 
cochlea was achieved through a bullotomy.  The burr hole, created using a drill (115 
Volt Dremel Drill, Mount Prospect) fitted with a 0.7 mm diamond burr drill bit, was 
situated in a triangular space illustrated in Figure 4 and bordered by: 1) the fissure 
between the mastoid process and tympanic bulla 2) the anterior insertion of the PBD 
3) the line joining these two boundaries that crosses the SF (Soken et al., 2013).  The 
drill was operated on a low power setting to insure that the stapedial artery (SA), a 
branch of the internal carotid artery that travels along the inferior border of the RW 
before passing through the crura of the stapes in the middle ear, was not ruptured ( 
Mistry et al., 2014).  Upon completion of drilling the burr hole, fine tip forceps were 
used to widen the opening thus allowing easier access to the RW (Mistry et al., 2014). 
The ventral surface of the animal was rotated forward for a better view of the RW.  If 
still intact, microforceps were used to penetrate and remove the RW membrane.  
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Evidence of the membrane removal was determined through leakage of perilymph 
fluid from the cochlea. A sterilized section of PVDF film was inserted into the RW 
using a pair of micro aural cup forceps. In some instances the width of the film was 
trimmed in order to fit appropriately.  The entire length of the film was inserted into 
the RW at which point resistance was met due to the decreasing diameter of the 
cochlea.  A section of trapezius fascia was inserted into the RW to secure the biofilm 
in the cochlea and suppress the flow of perilymph fluid.  SCM muscle fibers were then 
reattached followed by closure of the skin at the site of incision.   
Following the procedure, injections of 0.5 ml sterile saline and Buprenorphine 
(.1 ml/20g dosage) were given to the animal.  Three administrations of Carprofen (.1 
ml/10 g dosage) were given within the first 72 hours following surgery.  The site of 
incision and overall health of the animal were checked twice daily for the first 48 and 
once daily for 10 days following the initial 48 hour postoperative period.  Any signs 
of pain encountered post-operatively were relieved with administration of Carprofen.   
If the animal displayed severe head-tilt, signs of infection around the incision, or 
weight loss exceeding 20% of pre-operative weight, it was removed from the study.  
One animal in the 3 month survival length group was removed prematurely from the 
study due to unresolved tail lesions stemming from dermatitis. Yohimbime (Lloyd 
Laboratories, Shenandoah, IA) was administered twice postoperatively to aid in 
recovery from anesthesia. 
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Figure 4. 
Depiction of triangular area where burr hole is placed (Soken et al., 
2013).  Section of the posterior belly of digastric (PBD) removed that 
covers lateral portion of tympanic bulla (TB). Superior border of triangle 
is formed by mastoid process (MP). Facial nerve (CN VII) is shown 
exiting the temporal bone near proximal portion of triangle. 
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Figure 4. 
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Review of Tissue Extraction, Processing, and Examination 
Each animal was euthanized by CO2 inhalation at a designated time following 
implantation.  The mouse was decapitated and the cranium and surrounding 
musculature were placed in a solution of Cal-Rite decalcifying solution (Richard-Allen 
Scientific) for 4-6 days. Once the tissue had been sufficiently decalcified, further 
dissection was carried out to remove the bones of the cranium and expose only the 
temporal bone encasing both the right and left cochlea.  The tissue was then stored in 
a solution of 10% neutral buffered formalin until processing through a gradient of 
ethyl alcohol solutions and xylene.  Each sample was embedded in paraffin wax 
following the processing procedure.  The staining and sectioning of each sample was 
performed by AML laboratories (Baltimore, Maryland).  Ten Hemotoxylin and Eosin 
stained slides were made from each sample.  The tissue was cut every 8 microns with 
an individual section thickness of 5 microns.  
Both quantitative and qualitative analyses were used to determine the degree 
of inflammation in each implanted cochlea. Light microscopy analysis was performed 
on each slide to determine the degree of inflammation.  Each slide was analyzed on 
objectives ranging from low (2x) to high power (100x). The structural condition of 
cochlear structures and the composition of cochlear infiltrate was recorded.  If 
inflammation was present histopathological analysis identified certain cell types 
present which included neutrophils, erythrocytes, FBGCs, and fibrocytes (which 
included fibroblasts).  Individual counts of each cell type in implanted cochlea were 
performed and compared across treatment groups. The presence of any necrotic 
tissue and formation of multi-layered membrane was also recorded.  If present, the 
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width of the multi-layered membrane around the biofilm was measured. 
Qualitatively, the degree of damage to structures within the cochlea was assessed. 
Damage that existed as an artifact of tissue sectioning was not recorded.   The basilar 
membrane, tectorial membrane, Reissner’s membrane, stria vascularis, and the inner 
and outer hair cells of the Organ of Corti were analyzed to determine if the structure 
was damaged.  The membranes were determined to be damaged if there was a tear 
or rupture on the apical or basolateral surface. Organ of Corti damage was classified 
as displacement or degeneration of inner and outer hair cells.  Infiltration of 
erythrocytes into the Organ of Corti was recorded if observed.  To determine if the 
damage to the structures was due to damage from the biofilm or trauma from 
surgically accessing the cochlea, 3 control cochlea, representing each of the survival 
length groups, were examined. 
The cellular composition of the infiltrate within the cochlea was further 
analyzed using the image processing program, Image J (NIH, Bethesda, MD). Slides 
were first changed to grey-scale images used Adobe Photoshop Elements 7.0 (Adobe 
Systems, San Jose, CA).  The manipulated images were analyzed in Image J to 
determine both the area of the total infiltrate and infiltrate that exclusively contained 
cell types within the scala tympani. Image J measures the difference in intensities of 
individual pixels in a designated area on each image. A specific area, such as the scala 
tympani, can be sequestered from the rest of the image for analysis. Threshold for the 
minimum and maximum pixel size that is measured in the calculated area can be 
manipulated. The threshold range for the total cellular and acellular particulate 
infiltrate was set from 0 to 150, whereas the range for cellular infiltrate was set from 
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100 to 150. The measured areas in the scala tympani were compared across the three 
study groups.  
A final score was assigned to each animal that conveyed the intensity level of 
the FBR in the cochlea (Table 1). The score was based on a previous method for 
determining the degree of the FBR known as Sewell’s method (Black, 1999) (Sewell 
et al., 1955) (Gourlay et al., 1978). The scoring system was based on five 
measurements from our analysis.  Erythrocyte cell count, neutrophil cell count, FBGC 
count, and fibrocyte cell count were multiplied by a weighting factor that was 
previously determined.   The membrane width was assigned a value of 1-5 depending 
on the measured membrane width.  The cellular response for each animal was 
determined by summing the total amount of cells observed and assigning this value a 
score of 1-5.  Our scoring system and the ranges used to determine ranking were 
manipulated to account for the low objective we used to observe histological sections.  
The scores from each measurement were then summed to determine an overall 
ranking and intensity level of the FBR.  The assigned intensity levels were very mild, 
mild, moderate, severe, and very severe. 
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Table 1. 
 The assigned grade with the corresponding range of the measured thickness (μm) 
and cellular responses is shown in top table.  The cellular response is the total amount 
of cells within the area of the PVDF film implanted in the cochlea.  The middle table 
depicts the weighting factor for each measurement that was incorporated into the 
overall intensity level of the FBR for each animal.  The bottom table shows the ranges 
for the total score which is the sum of the five measurements in the middle table 
(cellular response, capsular thickness, neutrophil count, FBGC count, and fibrocyte 
count).  Each total score range has an assigned intensity level of the FBR.  The 
intensity levels range from the lowest level of very mild to the highest level of very 
severe. 
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TABLE 1. 
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 III.  RESULTS  
  
There was one case of premature removal of an animal from a test group in 
the study. All remaining specimens did not encounter health problems and survived 
until the end of their predetermined time length. Necropsy results did not show signs 
of necrosis or infection in any of the specimens. The implant was recoverable in 17 
out of 21 (81%) of the animals incorporated into our study. Statistical Analysis was 
conducted using SPSS (IBM, New York) and SAS (SAS Institute, North Carolina) 
computer software.  Statistical significance was determined with a reported P-value 
≤0.05.  
Qualitative Analysis of Cochlear Structures 
 Analysis using light microscopy of the 48 hour survival length group (n=6) 
revealed that the PVDF film was successfully implanted in the cochlea (Figures 5, 6).  
Cochlear structures were analyzed to determine if the structures had sustained any 
damage (Table 2).  The inner and outer hair cells of the Organ of Corti had significant 
damage in the majority of 48 survival length group specimens.  Infiltration of 
erythrocytes in the Organ of Corti was observed in two specimens.   In each of the 
specimens there were exudative products as a result of hemorrhage in the scala 
tympani accompanying the PVDF film. The exudate was composed of erythrocytes 
and inflammatory cells, most notably neutrophils. Thrombocytes were observed in 
each implanted cochlea and angiogenesis was not evident in any of the specimens. 
The stria vascularis was intact in each of the specimens. Damage to the scala tympani 
and Reissner’s membrane was observed in one specimen.  Damage to the tectorial 
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membrane and basilar membrane was observed in two specimens.  Control cochlea 
for the 48 hour survival length group showed exudate accumulation in the scala 
tympani (Figure 7).  Aside from one animal that had major structural damage to all 
examined cochlear structures, control cochlea sustained a minute amount of damage 
to their internal structures. 
The 3 week survival length group (n=7) had similar results to the 48 hour 
survival length group concerning the state of cochlear structures (Figures 8, 9) 
(Table 3). The inner hair cells and outer hair cells of the Organ of Corti were damaged 
in the majority of specimens. Along with the implanted film there was a multi-layered 
membrane surrounding the implant. Fibrocytes were found embedded within the 
collagenous matrix of the formed membrane.  FBGCs were observed within close 
proximity of the implant. Evidence of new blood vessel formation was observed in six 
of the specimens, while thrombocytes were observed in five of the specimens.  Similar 
to the 48 hour survival length animals but to a lesser extent, erythrocyte 
accumulation as a result of hemorrhage was observed. The 3 week survival length 
group control (Figure 10) specimens had exudate in the scala tympani composed 
primarily of erythrocytes and thrombocytes. Damage to Organ of Corti hair cells was 
sustained in two control specimens.  
The 3 month survival length group animals (n=4) had a multi-layered 
membrane formed around the implant with fibrocytes and FBGCs present (Figure 
11). Damage was observed to inner hair cells and outer hair cells in each specimen.  
Thrombocytes were evident in one 3 month survival length group specimen.  
Angiogenesis was not evident in any of the 3 month specimens.  The stria vascularis 
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and basilar membrane did not sustain damage for any of the 3 month specimens 
(Table 4). Thrombocytes were absent from 3 month control cochlea.  Damage to the 
Organ of Corti was evident in two of the 3 month control cochlea (Figure 12). 
The only measured parameter that was significantly different among the 
treatment groups was angiogenesis (P-value=.0002).  Angiogenesis was evident only 
in the 3 week survival length group and absence from the 48 hour and 3 month 
survival length groups.  A Fisher’s Exact Test was conducted on each measurement to 
determine significance between survival length groups. 
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Figure 5. 
10x image of implanted PVDF film (star) in scala tympani (ST) of 48 hour survival 
length group animal. Note the presence of exudate within the scala tympani 
composed of erythrocytes.  Exudative products were only present in the portion of 
the cochlea in which the PVDF film was implanted. 
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Figure 5. 
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Figure 6. 
20x image of PVDF film (Star) in scala tympani (ST). Note the exudate present 
composed of erythrocytes, inflammatory cells, and thrombocytes. 
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Figure 6. 
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Figure 7. 
10x control cochlear image from 48 Hour survival length group animal.  Note the 
absence of exudate from the scala tympani (ST). 
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Figure 7. 
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Table 2. 
Condition of cochlear structures which were observed for the 48 survival length 
group animals. Inner and outer hair cells were damaged in the majority of implanted 
animals.  The stria vascularis did not sustain damage in any of the implanted animals. 
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Table 2. 
Cochlear Structure Number of specimens 
with damaged structure 
Number of specimens with 
normal structure 
Basilar membrane 2 4 
Outer hair cells 5 1 
Inner hair cells 4 2 
Tectorial membrane 2 4 
Stria vascularis 0 6 
Scala tympani 1 5 
Reissner’s membrane 1 5 
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Figure 8. 
10x image of 3 week survival length group animal showing multi-layered membrane 
around PVDF film (star) in scala tympani.  Note the damaged inner and outer hair 
cells of the Organ of Corti (black box).  Fibrocytes were observed embedded in the 
membrane around the PVDF film (red box). 
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Figure 8. 
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Figure 9. 
100x objective image of a 3 week implanted animal with PVDF film (star) in the scala 
tympani and foreign body giants cells (red box) present. 
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Figure 9. 
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Table 3. 
Conditions of cochlear structures which were observed for the 3 week survival length 
group animals.  Outer and inner hair cells were damaged in the majority of implanted 
animals. 
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Table 3. 
Cochlear Structure Number of specimens 
with damaged structure 
Number of specimens 
with normal structure 
Basilar membrane 0 7 
Outer hair cells 5 2 
Inner hair cells 6 1 
Tectorial membrane 0 7 
Stria vascularis 1 6 
Scala tympani 1 6 
Reissner’s membrane 0 7 
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Figure 10. 
20x image of 3 week survival length group control cochlea with exudate present in 
scala tympani (ST).  Exudative products present were composed of inflammatory 
cells, erythrocytes, and thrombocytes (black box).  The stria vascularis (green arrow), 
Reissner’s membrane (blue arrow), and tectorial membrane (red arrow) did not 
sustain damage in this specimen. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
55  
  
Figure 10. 
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Figure 11. 
20x image of 3 month survival length group animal with PVDF film (star) surrounded 
by a membrane in the scala tympani. Note the presence of damage to the inner and 
outer hair cells of the Organ of Corti (black box) 
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Figure 11. 
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Figure 12. 
20x image of a control animal cochlea from the 3 month survival length group.  Note 
the absence of damage to the inner and outer hair cells of the Organ of Corti (black 
box). 
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Figure 12. 
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Table 4. 
Condition of cochlear structures which were observed for the 3 month survival group 
animals.  There was damage to the inner and outer hair cells of the Organ of Corti in 
each of the specimens.  Damage to the scala tympani was evident in three of the 
specimens.   
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Table 4. 
Cochlear Structure Number of specimens 
with damaged structure 
Number of specimens 
with normal structure 
Basilar membrane 0 4 
Outer hair cells 4 0 
Inner hair cells 4 0 
Tectorial membrane 2 2 
Stria vascularis 0 4 
Scala tympani 3 1 
Reissner’s membrane 0 4 
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Quantitative Analysis of Cochlear Exudate 
 The average count of cell types involved in the FBR was determined by light 
microscopy examination of sample slides using the 20x and 40x objectives. Statistical 
significance was determined using a 1-way ANOVA. Erythrocyte cell count levels 
(Figure 13) were shown to significantly decrease between the 48 hour and 3 week 
survival length groups (P-value=.030).  The 3 month survival length group showed a 
slight increase in erythrocyte cell count level compared to the 3 week survival length 
group, but this observation was not significant.  Neutrophil cell count levels (Figure 
13) were observed at the highest intensity in the 48 hour survival length group. There 
was a significant decrease in neutrophil cell count levels between the 48 hour and 3 
week (P-value=.022), and the 48 hour and 3 month survival length groups (P-
value=.028).   
 Three measured parameters were observed only in the 3 week and 3 month 
survival length groups.  Fibrocyte cell count levels (Figure 14) increased significantly 
between the 48 hour and 3 week survival length groups (P-value=0.001).  FBGC levels 
(Figure 15) increased significantly between the 48 hour and 3 week survival lengths 
(P-value=0.001). The average membrane width around the PVDF film (Figure 14) 
increased significantly between the 48 hour and 3 week (P-value=.002) and 48 hour 
and 3 month (P-value=.049) survival length groups. 
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Figure 13. 
Graph and corresponding table depicting the average cell counts for erythrocytes and 
neutrophils in implanted specimens and a representative control specimen. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
64  
  
Figure 13. 
 
Test 
Group 48 Hour 3 Week 3 Month 
Average 188.7 41.5 59 
 
 
Study Group 48 Hour 3 Week 3 Month 
Average 14.1 3.5 2.6 
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Figure 14. 
Graph and corresponding table depicting the average membrane width (µm) and 
average cell counts for fibrocytes in implanted specimens and a representative 
control specimen. 
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Figure 14. 
   
Study Group 48 Hour 3 Week 3 Month 
Average 0 27.3 19.4 
 
 
 
FC Data 48HR 3Week 3months 
Average 0 70.75 36.4 
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Figure 15. 
Graph and corresponding table depicting the average cell counts for FBGCs in 
implanted specimens and a representative control specimen. 
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Figure 15. 
 
Study Group 48 Hour 3 Week 3 Month 
Average 0 2.4 1 
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Summary of intensity levels of the FBR assigned to each animal 
 Five parameters were ranked for each animal to determine a final score for the 
FBR.  This score corresponded to certain intensity level of the FBR in the cochlea.  The 
method used to rank the FBR in this research had a range of low intensity levels (very 
mild and mild), a moderate intensity level, and high intensity levels (severe and very 
severe).  The 3 week survival length group had the highest total score average of the 
3 implanted test groups.  There was a significant increase between the 48 Hour and 3 
week time points (P-value=0.020). The majority of FBR degrees were mild with the 
highest intensity level observed being very mild.  The Kruskal-Wallis test was used to 
statistically analyze the total scores of implant animals.   
  
  
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
70  
  
Figure 16. 
Graph displaying the average intensity levels for the 3 survival length 
groups.  The intensity levels of the FBR for each animals are shown in 
the three survival length group tables.  Note that the majority of the 
animals had a mild intensity level of the FBR.  Mild was the lowest 
assigned intensity level.  Three of the animals in the 3 week survival 
length group had a very mild intensity level of the FBR.   
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Figure 16. 
 
 
Group 48 Hour 3 Week 3 Month 
Average 34.9 91.8 52 
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 IV.  DISCUSSION  
          The main objective of this research was to determine if PVDF film was 
biocompatible in the murine cochlea. Upon review of cochlear tissue extracted from 
each of the implanted animals no evidence was found of necrotic tissue or infection.  
The FBR observed in response to the implanted PVDF was a normal stereotypical 
reaction that commonly accompanies implanted biomaterials. 
Summary of the measured acute responses of the FBR to PVDF film 
            The observed acute responses of the FBR included erythrocyte accumulation 
and infiltration of neutrophils around the site of implantation. Hemorrhage as a result 
of trauma to surrounding vasculature, vasodilation, and increase permeability of 
capillaries and venules leads to elevated erythrocyte cell counts at the site of 
implantation (Cheville, 1988).  Erythrocyte cell count levels decreased significantly 
between the 48 hour and 3 week survival length groups.  Leukocytes, most notably 
neutrophils, leave the vasculature during the acute phase and migrate toward the 
region of the implant material in response to chemotactic factors (Cheville, 1988).  
Neutrophil cell count levels decreased significantly between the 48 hour and 3 week 
survival length groups.  The acute response of the FBR was a transient period that 
was observed in the 48 hour survival length group and did not progress into the 3 
week survival length group. The neutrophil cell counts observed in each of our study 
groups corresponded to the inflammatory cell levels shown to accompany 
biocompatible materials;  neutrophil presence at the site of biocompatible implants 
has been previously shown to resolve by 3 weeks post-implantation (Hollinger, 
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2012).  The decrease in the amount of erythrocyte at the implant site suggests that 
PVDF film does not interrupt the blood coagulation and clotting mechanisms of the 
host.  Platelets were observed at the implant site only in the test group with the 
highest levels of erythrocytes, the 48 survival length group.  Following a traumatic 
event to vasculature, platelets along with plasma protein stem the flow of blood by 
sealing off and repairing damaged vessels (Slauson and Cooper, 1982).   
Summary of the measured chronic responses of the FBR to PVDF film            
           The chronic phase of the FBR is characterized in part by a multi-layered 
membrane forming around the implanted material and the presence of fibrocytes and 
FBGCs (Hollinger, 2012).  Our study observed these responses in the 3 week and 3 
month survival length groups.  There was a not a significant increase in the membrane 
width and presence of FBGCs and fibrocytes between the 3 week and 3 month 
survival length groups.  The composition and integrity of the PVDF film was not 
affected by the chronic response of the FBR.  Previous research has shown that 
inappropriate interfaces between implanted materials and the body can arise from 
allergic immune responses from the host in response to toxic or immunogenic 
material particulates (Hollinger, 2012). This atypical host response can result in 
damage and rupture to electrical leads, glucose sensors, and silicone breast implants 
(Hollinger, 2012). 
Summary of the assigned intensity levels of the FBR            
           The total score for each animal also revealed that the 3 week time period 
contained the highest average intensity level among the three test groups.  There was 
74  
  
a significant increase between the 48 hour and the 3 week survival length groups.   
The intensity of the FBR for the majority of specimens was graded at the lowest level, 
mild. The highest intensity of the FBR observed was very mild, which was assigned to 
3 animals. These measured intensity levels of the FBR are a significant indicator of 
the biocompatibility of PVDF film because they reveal that both acute and chronic 
responses of the FBR present at the implant site of the film were at a significantly low 
degree over the entire time PVDF film was present in the mouse cochlea.  
Summary of cochlear structural conditions and exudative area 
            The basilar membrane, stria vascularis, and scala tympani were intact in the 
vast majority of implanted animals.  Upon examination of cochlear structures there 
was damage sustained to the inner and outer hair cells of the Organ of Corti in the 
majority of implanted animals. Damage to the hair cells of the Organ of Corti was also 
seen in the cochlea that received sham surgeries.  Angiogenesis was shown to be 
significantly different between the three survival length group groups with it being 
observed only in the 3 week survival length group.  Angiogenesis is a normal 
component of wound healing that promotes vascular growth and is present during 
the phase of inflammation before tissue reconstruction which leads to scar formation 
(Silver and Doilon, 1989). 
              We speculate that there are two possible sources contributing to the damaged 
inner and outer hair cells observed in the implanted and control cochlea.  A recent 
study has shown that damage is sustained to the Organ of Corti when the cochlea is 
accessed through a round window cochleostomy (Kopelovich, 2015).  Test cochlea 
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that received three different implant types along with sham cochlea showed damage 
to inner and outer hair cells.    The damage to the Organ of Corti was correlated with 
hearing loss observed 2 weeks after the procedure (Kopelovich, 2015).  Another 
possible source is that the strain of mice we used in the study, C57bl/6, have genetic 
defects that lead to hair cell degeneration.  C57bl/6 mice are used in research because 
of their accurate depiction of age-related hearing loss.  A previous study showed that 
hair cell degeneration is evident as early as 30 days post-partum in C57bl/6 mice 
(Shnerson et al., 1981).  All of the animals in our study were over 30 days of age.  This 
record of hair cell degeneration may be a possible source of the damage to hair cells 
recorded in our study. 
Concluding remarks on biocompatibility of PVDF film  
           We determined the biocompatibility of PVDF film based on the observations 
that there was no evidence of infection or necrosis in cochlear tissue, the implant was 
not extruded from the cochlea, and there was not a prolonged FBR following the 
transient acute inflammation phase.  Components of the FBR were not found in areas 
of the cochlea outside the site of implantation.  The FBR was at the lowest possible 
intensity level for the majority of the time the PVDF film was implanted in the cochlea.  
Damage to the Organ of Corti that was observed in the majority of implanted and 
sham cochlea may be attributed to factors not related to the presence of the PVDF 
film.  Chronic inflammation responses were observed in the 3 week and 3 month 
survival length.  More notably, presence of FBGCs, fibrocytes and membrane 
formation have been observed around implants removed from the body.   
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 Future Experiments  
 The research described in this paper can be expanded upon by identifying if a 
time point exists were the chronic responses of the FBR, primarily membrane 
formation, FBGCs, and fibrocyte presence, decrease beyond the 3 month time period. 
The acute response of the FBR were shown to significantly decrease at the 3 week 
time period, with the highest levels seen at the 48 hour time period. The only 
difference between this future study and the current study would be that a 4th test 
group would be added with a survival length of 6 months.   
 
 One aspect of biocompatibility not touched upon in this research is if PVDF 
film is detrimental to the residual hearing in the cochlea; does the presence of the 
PVDF film and the resulting FBR in response to the implanted film damage the Organ 
of Corti, basilar membrane, or other cellular structures causing sensorineural hearing 
loss. This can be tested using Auditory Brainstem Responses (ABRs).  An ABR is a type 
of auditory evoked potential that uses electrodes to measure auditory function 
(Willott, 2001). The recorded electrical potential can be from many different steps in 
the auditory pathway depending on several factors in the testing procedure, such as 
placement of electrodes, frequency, and wavelength measured (Willott, 2001).    
Baseline levels of auditory function would be measured using an external stimulus, 
such as a click tone, from test and sham cochlea at the start of the study. Following 
implantation with PVDF film, study groups would be assigned a period of 48 hours, 3 
weeks, or 3 months that corresponds to the amount of time the PVDF film is inserted 
in the cochlea. ABRs are recorded at the end of the assigned time period for each 
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animal. Baseline and test ABRs are compared to observe any fluctuation or decrease 
in auditory function. 
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